Latest revenue
$26.0M
as of 2026-03-31
Latest net income
$-21.3M
as of 2026-03-31
Net margin
-81.9%
as of 2026-03-31
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $1.39B
- Enterprise value
- $1.39B
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $27.20
- 52-wk low
- $19.87
- Beta
- —
- Shares out
- 69.3M
5-year trend
About ALMR
Business description and risk factors will appear here once ALMR's latest filing is fully ingested.
Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q1 2026 2026-03-31 | $26.0M | +98.9% | $-21.3M | -178.4% | -81.9% |
Q1 2025 2025-03-31 | $13.1M | — | $-7.7M | — | -58.5% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Laboratory Analytical Instruments · SIC 3826
Your notes
Keep private notes on ALMR — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$8.0M
Insider selling
$0
Net activity
+$8.0M
Distinct insiders
2
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ALMR
No institutional holdings on file for ALMR yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once ALMR's latest filing finishes processing.